Published in Cells on July 30, 2012
Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis. Cells (2014) 1.49
Normal Distribution of CD8+ T-Cell-Derived ELISPOT Counts within Replicates Justifies the Reliance on Parametric Statistics for Identifying Positive Responses. Cells (2015) 0.87
High Reproducibility of ELISPOT Counts from Nine Different Laboratories. Cells (2015) 0.83
How much of virus-specific CD8 T cell reactivity is detected with a peptide pool when compared to individual peptides? Viruses (2012) 0.79
Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay. Cells (2015) 0.79
How frequently are predicted peptides actually recognized by CD8 cells? Cancer Immunol Immunother (2016) 0.75
Delayed Activation Kinetics of Th2- and Th17 Cells Compared to Th1 Cells. Cells (2017) 0.75
Immunosuppressive effects of apoptotic cells. Nature (1997) 7.03
The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ (1998) 3.23
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother (2007) 3.16
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J Immunother (2002) 2.65
Apoptotic cell removal in development and tissue homeostasis. Trends Immunol (2006) 2.51
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother (2007) 2.49
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC. AIDS Res Hum Retroviruses (2007) 2.27
CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods (2003) 1.98
Standardization and validation issues of the ELISPOT assay. Methods Mol Biol (2005) 1.79
Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest (2008) 1.78
Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J Immunol (2000) 1.61
Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J Immunol (2000) 1.43
Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol (2002) 1.32
Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood (1992) 1.30
Equivalence of ELISpot assays demonstrated between major HIV network laboratories. PLoS One (2010) 1.30
Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun (2003) 1.25
Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods (2000) 1.17
Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J Immunol Methods (2003) 1.15
Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense. Immunol Invest (2000) 1.15
Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies. Cells (2012) 1.12
IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assays. Cell Immunol (2005) 1.10
Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells. Cell Immunol (2007) 1.08
Unique strengths of ELISPOT for T cell diagnostics. Methods Mol Biol (2012) 1.07
Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection. AIDS Res Hum Retroviruses (2008) 1.04
Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J Immunol (2000) 1.04
Detection and quantification of drug-specific T cells in penicillin allergy. Allergy (2009) 1.03
Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J Immunol (2007) 1.03
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets. J Transl Med (2004) 1.01
Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine (2006) 0.99
Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells. J Immunol (2009) 0.98
Image analysis and data management of ELISPOT assay results. Methods Mol Biol (2005) 0.97
Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin. Hum Immunol (2011) 0.96
Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. J Immunol Methods (2009) 0.95
Quantification of tumor-specific T lymphocytes with the ELISPOT assay. J Immunother (2000) 0.91
Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol (2002) 0.90
Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol Rep (2005) 0.90
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects. Hum Vaccin (2005) 0.80
Immunologic testing of xeno-derived osteochondral grafts using peripheral blood mononuclear cells from healthy human donors. BMC Musculoskelet Disord (2005) 0.80